Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stora Enso: Managers’ transactions – Völkel

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 5 March 2024 at 9:00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Lars Völkel Position: Other senior manager Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 54365/6/6 ____________________________________________ Transaction date: 2024-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009005961 Nature of transaction: RECEIPT OF A SHARE-

Stora Enso: Managers’ transactions –Bäärnman

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 5 March 2024 at 9:00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tobias Bäärnman Position: Other senior manager Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 54334/4/4 ____________________________________________ Transaction date: 2024-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009005961 Nature of transaction: RECEIPT OF A SHARE-

Stora Enso: Managers’ transactions – Hagelberg

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 5 March 2024 at 9:00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Johanna Hagelberg Position: Other senior manager Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 54317/11/8 ____________________________________________ Transaction date: 2024-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009005961 Nature of transaction: RECEIPT OF A

Stora Enso: Managers’ transactions – Kasurinen

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 5 March 2024 at 9:00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hannu Kasurinen Position: Other senior manager Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 54331/6/6 ____________________________________________ Transaction date: 2024-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009005961 Nature of transaction: RECEIPT OF A SHARE-

Stora Enso: Managers’ transactions – Kravi

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 5 March 2024 at 9:00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Katariina Kravi Position: Other senior manager  Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 54337/4/4 ____________________________________________ Transaction date: 2024-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009005961 Nature of transaction: RECEIPT OF A

Södra to invest in green electricity generation at Mörrum

Södra has decided to invest in a new condensing turbine in the pulp mill at Mörrum, which will increase the county of Blekinge’s electricity generation by 20 percent. The investment, amounting to several hundreds of millions of Swedish kronor, is a major and important step for Södra in strengthening competitiveness by utilising more of the wood raw material from family forestry and thereby increasing the profitability of forest estatesWe are facing a growing demand for electricity as part of society’s green transition. At the same time, a significant increase in electricity consumption is

New clinical study to evaluate QuickMIC® in the diagnostic workflow of urosepsis

Uppsala, Sweden, March 5, 2024. The diagnostics company Gradientech today announces the start of a new prospective and observational QuickMIC® study in collaboration with Assoc. Prof. Martin Sundqvist at Örebro University Hospital.The study, initiated by Dr Sundqvist, will investigate the clinical utility of a new rapid workflow for prediction of optimal antibiotic treatment for patients with urosepsis. Urosepsis is caused by infections of the urinary tract where the sepsis causing bacteria are hence present in the urine and often, but not always, also in the patient’s blood. Results

Repurchases of shares during week 9, 2024

Between 26 February and 01 March 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 151,720 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 8 February 2024. The repurchase program, which runs between 9 February 2024 and 24 April 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (

INSIDE INFORMATION: Tietoevry announces a consent solicitation in respect of its EUR 300 000 000 notes due 2025 to enable the separation of its Banking business

Tietoevry Corporation     INSIDE INFORMATION     5 March 2024, 9:00 a.m. EET   NOT FOR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN OR AT ANY ADDRESS IN, THE UNITED STATES. IN PARTICULAR, THIS PRESENTATION AND THE CONSENT SOLICITATION FOLLOWING THIS PRESENTATION SHALL NOT BE DISTRIBUTED, TRANSMITTED OR FORWARDED, DIRECTLY OR INDIRECTLY, IN OR INTO, OR BY USE OF THE MAILS OF, OR BY ANY MEANS OR INSTRUMENTALITY (INCLUDING, WITHOUT LIMITATION, FACSIMILE TRANSMISSION, TELEX, TELEPHONE, EMAIL AND OTHER FORMS OF ELECTRONIC COMMUNICATION) OF INTERSTATE OR FOREIGN COMMERCE

All patients included in Stayble Therapeutics' phase Ib study in disc hernia with STA363

Stayble Therapeutics AB ("Stayble" or the "Company") announces today that the last patient has been included in the ongoing phase Ib clinical study with STA363 towards disc hernia. No significant side effects have so far been reported and currently, none of the included patients has discontinued their participation in the study. Results from the study are expected to be available in Q4 2024.The ongoing clinical trial, conducted in collaboration with the contract research company CromSource and at four clinics in Poland, is a double-blind, placebo-controlled trial aimed primarily at studying

MaserFrakt’s new hydrogen-powered trucks will refuel at Hynion’s hydrogen refueling stations

The transport group MaserFrakt has invested in two hydrogen trucks of the brand Holthausen Clean Technology. The first truck was delivered to Borlänge last week, from where it will operate. The trucks will have the possibility to be refueled at Hynion's hydrogen refueling stations in Sandviken, Västerås and Jönköping, in addition to the hydrogen refueling station that is operated under their own management in Borlänge.­­­[MaserFrakt tankar hos Hynion] MaserFrakt aims for only fossil-free transport in 2030 and is the first company in Sweden with hydrogen-powered heavy trucks in its

Metso’s sustainable production process gains ground in the production of battery-grade lithium hydroxide

Metso Corporation’s press release on March 5, 2024, at 09:00 a.m. EETTo cater for the rapidly increasing demand for battery-grade lithium required for the energy transition, Metso has reviewed its lithium hydroxide technology and service offering. As part of this comprehensive review, Metso’s proprietary, sulphate-free alkaline pressure leach process has been validated as a Planet Positive  technology for the production of battery-grade lithium. Metso’s hydrometallurgical alkaline leach process is a simple and

Outokumpu and Langh Ship aim to reduce carbon emissions from short sea liner operation by at least 25% by the end of 2024

Outokumpu Oyj Press release March 5, 2024 at 9.00 am EEST Outokumpu and Langh Ship aim to reduce carbon emissions from short sea liner operation by at least 25% by the end of 2024   Outokumpu, the global leader in sustainable stainless steel, is deepening its long-term transport collaboration with Finnish shipping company Langh Ship, by taking into use new energy-efficient and low-emission vessels during 2024. The first multipurpose vessel, Lovisa, has started its liner service for Outokumpu between Finland and the Netherlands. Outokumpu aims to have six vessels in use from

Scania publishes Annual and Sustainability Report for 2023: “Significant growth in sales and earnings and continued progress on sustainability performance”

Scania continued performing strongly during the year, increasing both sales and earnings significantly. Scania’s Annual and Sustainability report is published today, detailing its financial, social and environmental performance in 2023.Summary of the full year 2023: · Scania Group net sales grew by 28 percent to SEK 204.1 billion (159.2) · Adjusted operating income reached SEK 26.0 billion (14.0) and adjusted operating margin was 12.7 percent (8.8) · Deliveries increased by 13 percent to 96,727 vehicles, whereof Zero Emission Vehicles (ZEV) amounted to 246 units (262) ·

Orthex Corporation: Financial statements release 2023

Orthex Corporation, Stock exchange release, 5 March 2024 at 9.00 a.m. EETStrong profitability and record sales in the last quarter of 2023 This release is a summary of Orthex Corporation’s Financial statements release 2023. The complete report is attached to this release as a pdf-file. It is also available on Orthex’s website at https://investors.orthexgroup.com/.October–December 2023 · Invoiced sales were EUR 23.9 million (20.6) · Net sales increased by 15.0% to EUR 23.4 million (20.4) · Adjusted EBITDA was EUR 3.9 million (2.6) · Adjusted EBITA was EUR 2.9 million (1.

Implantica announces another major public hospital purchase agreement win in Italy, further strengthening RefluxStop™’s broader acceptance in public healthcare systems in Europe

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another public hospital purchase agreement for RefluxStop™ this time at the IRCCS Saverio De Bellis in Bari, Puglia, Italy.In September 2023, six RefluxStop™ procedures were performed at IRCCS Saverio De Bellis by Dr. Leonardo Vincenti. IRCCS De Bellis is one of the top research hospitals in Italy entirely focused on the treatment of Gastroenterological disease. All six patients have recovered well. In February 2024, the hospital signed an annual agreement to buy up to 36

Change in Pihlajalinna’s Management Team

Pihlajalinna Plc                   Stock Exchange Release                      5 March 2024 at 9:00 a.m. Change in Pihlajalinna’s Management Team Antti-Jussi Aro, the Chief Information Officer of Pihlajalinna Plc, has decided to leave the company. His final operating day will be on 10 May 2024. The recruitment process for the successor has started. – I want to thank Antti-Jussi for his valuable contribution to develop Pihlajalinna’s IT and digital capability. Promoting information security, data protection, seamless interfaces, and digital business are essential for enabling

Exel Composites Plc’s Annual Report 2023 published

EXEL COMPOSITES PLC     STOCK EXCHANGE RELEASE       5.3.2024 at 09:00 EETExel Composites’ Annual Report, Remuneration Report and Corporate Governance Statement for 2023 have been published today. The Annual Report includes the Board of Directors’ Report, the review by the President and CEO, the consolidated financial statements, the financial statements of the parent company and the auditor’s report. Exel Composites publishes the financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements. The format of the report is XHTML. In line with

Hufvudstaden welcomes Icebug to Bibliotekstan

In the spring of 2024, Swedish shoe label Icebug will open a brand store of approximately 80 square metres at Norrlandsgatan 10 in Bibliotekstan, central Stockholm, which will be the brand’s first pure brand store in Stockholm. Icebug specialises in shoes for outdoor activities and winter conditions.Icebug was founded in 2001 by mother and son team Eliza Törnkvist and David Ekelund. Their business idea was to make reliable and grippy shoes so that more people could get out and enjoy nature. With its unique product, Icebug quickly established itself as a trusted brand in the footwear world,

NCC to build new school in Västerås

NCC will build a new school with associated sports hall and schoolyard in partnership with the City of Västerås in Sweden. The new school will be located in Fredriksdal, part of the growing Gäddeholm area, east of Västerås. The project is a turnkey contract in partnering form with an order value of approximately SEK 450 million. New school in Västeås. Visualization Archus Arkitekter NCC has entered into a partnership with the City of Västerås to build a new school with associated sports hall for 700 students aged 6–16 years. The new school will also be prepared to accommodate

Nordhealth AS: Q4 and second half 2023 interim financial report

Please find attached the Q4 presentation and interim financial report of Nordhealth AS second half 2023 results.The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Mari Orttenvuori on the 5th of March 2024 at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/83057714357 The presentation will be recorded and made available on www.nordhealth.com. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200  Mari Orttenvuori, CFO mari.orttenvuori@

Notice to Solteq Plc’s Annual General Meeting 2024

Stock Exchange BulletinNotice to General MeetingMarch 5, 2024, at 8:05 a.m. Shareholders of Solteq Plc are hereby invited to the Annual General Meeting to be held on Wednesday 27 March 2024 at 10:00 (EET). The Annual General Meeting will be held without a meeting venue via real-time remote access in accordance with 11 § of the company’s Articles of Association and Chapter 5, Section 16 (3) of the Finnish Limited Liability Companies Act. Instructions for participation are set out in Part C of this Notice of Annual General Meeting. Shareholders can also exercise their voting rights

Everfuel – Q4 2023: Preparing for green hydrogen ramp-up

Herning, Denmark, 05 March 2023 – Everfuel A/S today published its fourth quarter financial results and annual report for 2023. Key events Q4 2023: · Everfuel and Hy24 JV signs final agreement for first ever Danish PtX tender, securing EUR 28.3 million of green hydrogen production support · Entered strategic collaboration with Japanese industry blue-chips ITOCHU and Osaka Gas · Q4 EBITDA of -3.4 million · EUR 6.8 million non-cash write down of legacy hydrogen stations and equipment · Cash position of EUR 28.6 million at end of December 2023 · Current liquidity

Camurus announces FDA acceptance of NDA submission for Oclaiz™ for treatment of acromegaly

Prescription Drug User Fee Act date (PDUFA) set to 21 October 2024 Lund, Sweden — 5 March 2024 — Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for Oclaiz[TM] (CAM2029) for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of 21 October 2024. CAM2029 is a novel, octreotide subcutaneous depot designed for convenient, once-monthly self-administration, enhanced octreotide plasma exposure, and robust disease

There are no items matching the current filter
There are no more items matching the current filter
Back to top